v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Stock-Based Compensation  
Schedule of stock option activity

Number of

Weighted average

  

shares

  

price per share

  

Outstanding as of January 1, 2025

 

311

$

265.36

Granted

75

$

7.54

Forfeited

(5)

$

124.94

Cancelled

(14)

$

384.60

Exercised

$

Outstanding as of March 31, 2025

367

$

210.27

Options vested and exercisable as of March 31, 2025

 

259

$

268.46

Schedule of stock-based compensation charges

Three months ended March 31, 

2025

2024

Research and development

$

(514)

$

1,281

Selling, general and administrative

 

694

2,152

Total

$

180

$

3,433

BTI RSU  
Stock-Based Compensation  
Schedule of activity relating to RSUs

Number of

  

shares

Outstanding as of January 1, 2025

 

27

Granted

3

Cancelled

(1)

Vested

(9)

Outstanding as of March 31, 2025

20

BTI PSU  
Stock-Based Compensation  
Schedule of activity relating to PSUs

Number of

  

shares

Outstanding as of January 1, 2025

 

70

Granted

Cancelled

(10)

Exercised

Outstanding as of March 31, 2025

60

OnkosXcel PSU  
Stock-Based Compensation  
Schedule of activity relating to PSUs

Weighted average

Number of

price per unit

  

units

(in whole dollars)

Outstanding as of January 1, 2025

 

1,166

$

5,686

Granted

$

Cancelled

(84)

$

6,006

Forfeited

$

Outstanding as of March 31, 2025

1,082

Vested units as of March 31, 2025

976

$

5,533

Schedule of Valuation Assumptions

2024 grant profit share unit valuation inputs

Expected volatility

97.4

%

Risk-free rate of interest

3.6

%

Expected dividend yield

%

Expected term

5.8

years

OnkosXcel RSUs  
Stock-Based Compensation  
Schedule of activity relating to RSUs

Number of

  

units

Outstanding as of January 1, 2025

 

176

Granted

Vested

(2)

Cancelled

(34)

Outstanding as of March 31, 2025

140

Employee Stock Option  
Stock-Based Compensation  
Schedule of Valuation Assumptions

Three months ended

Three months ended

    

March 31, 2025

March 31, 2024

Expected term

5.3

years

6.1

years

Expected stock price volatility

112.0

%

108.4

%

Risk-free rate of interest

4.5

%

4.0

%

Expected dividend yield

0.0

%

0.0

%